HOLX holds $40

by Christian Tharp, CMT |

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally.

Take a look at the 1-year chart of Hologic (NASDAQ: HOLX) below with my added notations:

HOLX had formed a key $40 level (green) of resistance for the few months leading up to June. However, the stock broke through that resistance last week, and now that HOLX is sitting back on the $40 support, a bounce could be expected.

The Tale of the Tape: HOLX broke through its key level of resistance at $40. A long trade could be entered on a pull back down to that level. However, a break back below $40 could negate the forecast for a higher move and would be an opportunity to get short the stock.

Before making any trading decision, decide which side of the trade you believe gives you the highest probability of success. Do you prefer the short side of the market, long side, or do you want to be in the market at all? If you haven’t thought about it, review the overall indices themselves. For example, take a look at the S&P 500. Is it trending higher or lower? Has it recently broken through a key resistance or support level? Making these decisions ahead of time will help you decide which side of the trade you believe gives you the best opportunities.

No matter what your strategy or when you decide to enter, always remember to use protective stops and you’ll be around for the next trade. Capital preservation is always key!

Christian Tharp, CMT


Our Experts Found 9 Stocks You Will Hold Forever

With individual stock selection now more critical than ever, this report is designed to bring you some of our top ideas for the year ahead. One of the companies highlighted in this report controls the smartphone market and now has its sights set on owning a bigger technology. It has the potential to be the most valuable stock in the history of investing. You need to find out the name of this company before the rest of the market does. This Report Is Completely Free, Download Your Copy Today